Global lactose market projected to reach $4.6B by 2033

By AI, Created 11:51 AM UTC, May 28, 2026, /AGP/ – The global lactose market is forecast to rise from $3.1 billion in 2026 to $4.6 billion by 2033, driven by pharmaceutical excipient demand, infant formula growth and wider use in processed foods. Europe leads today, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Lactose sits at the center of food, pharma and infant nutrition supply chains. - The market’s projected rise to US$4.6 billion by 2033 signals steady demand for dairy-derived ingredients with both functional and nutritional roles. - Growth in pharmaceutical-grade lactose matters because tablet manufacturing depends on reliable, high-purity excipients. - Expansion in infant formula production matters because lactose is a core carbohydrate source in infant nutrition products.

What happened: - The global lactose market is expected to grow from US$3.1 billion in 2026 to US$4.6 billion by 2033. - The forecast implies a 5.7% compound annual growth rate from 2026 to 2033. - Persistence Market Research linked the outlook to stronger demand from food processing, pharmaceuticals and specialized nutrition. - The report was published in London on May 28, 2026. - The release includes sample report access, customization requests and checkout information.

The details: - Lactose is a naturally occurring sugar derived from whey during dairy processing. - Food makers use lactose as a sweetener, flavor enhancer and texturizing agent. - Pharmaceutical companies use lactose as an excipient in tablet formulation because of its compressibility and compatibility with active ingredients. - Infant formula manufacturers rely on lactose as a carbohydrate source that closely mimics human milk composition. - Rising demand for processed and packaged foods is adding to market growth. - Higher infant formula production in emerging economies is strengthening demand. - Whey-based ingredients are gaining traction in functional foods and sports nutrition as consumers favor protein-rich and clean-label products. - Advances in dairy processing and separation technology are improving lactose purity, production efficiency and cost optimization. - The market is segmented by product type into lactulose, galactose and lactose monohydrate. - The market is segmented by form into powder and granule. - End uses include food and beverage, infant formula, pharmaceuticals, animal feed and others. - Key companies listed in the market include Fonterra Co-Operative Group Limited, Arla Foods amba, Royal FrieslandCampina NV, Kerry Group plc, Saputo Inc., Lactalis Ingredients, DMK Group, Agropur, Leprino Foods and Hilmar Ingredients.

Between the lines: - The report points to a market that is less about consumer-facing lactose and more about industrial reliability, purity and scale. - Pharmaceutical demand can support pricing and margin stability because excipient quality requirements are stricter than in many food uses. - Asia-Pacific’s growth outlook suggests demand is shifting toward countries with rising incomes, larger populations and expanding drug manufacturing. - Automation, real-time monitoring and AI tools are becoming part of lactose production as manufacturers push for better yield and fewer losses. - Europe remains dominant because of its established dairy base, advanced processing infrastructure and strong pharmaceutical and food industries. - North America’s role is supported by pharmaceutical manufacturing and demand for processed and convenience foods. - Latin America and the Middle East & Africa are growing more slowly, but urbanization and better healthcare access are opening new opportunities.

What’s next: - Demand growth is likely to track pharmaceutical expansion, infant nutrition sales and processed food consumption through 2033. - Dairy processors are expected to keep investing in filtration, crystallization, drying and digital monitoring systems. - AI, IoT and automation could further improve consistency, lower costs and reduce waste across the supply chain. - New applications in nutraceuticals, biotechnology and personalized nutrition may broaden the market beyond current end uses.

The bottom line: - Lactose is moving from a basic dairy byproduct to a higher-value industrial ingredient, with pharma and infant nutrition doing most of the heavy lifting.